Literature DB >> 19756021

Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.

Jason S Weinstein1, Csanad G Varallyay, Edit Dosa, Seymur Gahramanov, Bronwyn Hamilton, William D Rooney, Leslie L Muldoon, Edward A Neuwelt.   

Abstract

Superparamagnetic iron oxide nanoparticles have diverse diagnostic and potential therapeutic applications in the central nervous system (CNS). They are useful as magnetic resonance imaging (MRI) contrast agents to evaluate: areas of blood-brain barrier (BBB) dysfunction related to tumors and other neuroinflammatory pathologies, the cerebrovasculature using perfusion-weighted MRI sequences, and in vivo cellular tracking in CNS disease or injury. Novel, targeted, nanoparticle synthesis strategies will allow for a rapidly expanding range of applications in patients with brain tumors, cerebral ischemia or stroke, carotid atherosclerosis, multiple sclerosis, traumatic brain injury, and epilepsy. These strategies may ultimately improve disease detection, therapeutic monitoring, and treatment efficacy especially in the context of antiangiogenic chemotherapy and antiinflammatory medications. The purpose of this review is to outline the current status of superparamagnetic iron oxide nanoparticles in the context of biomedical nanotechnology as they apply to diagnostic MRI and potential therapeutic applications in neurooncology and other CNS inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756021      PMCID: PMC2949106          DOI: 10.1038/jcbfm.2009.192

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  125 in total

Review 1.  Present status of magnetic resonance imaging and spectroscopy in animal stroke models.

Authors:  Ralph Weber; Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  J Cereb Blood Flow Metab       Date:  2006-05       Impact factor: 6.200

Review 2.  New developments in MRI for target volume delineation in radiotherapy.

Authors:  V S Khoo; D L Joon
Journal:  Br J Radiol       Date:  2006-09       Impact factor: 3.039

Review 3.  Superparamagnetic iron oxide nanoparticle probes for molecular imaging.

Authors:  Daniel L J Thorek; Antony K Chen; Julie Czupryna; Andrew Tsourkas
Journal:  Ann Biomed Eng       Date:  2006-02-16       Impact factor: 3.934

4.  Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.

Authors:  L L Muldoon; P G Tratnyek; P M Jacobs; N D Doolittle; G A Christoforidis; J A Frank; M Lindau; P R Lockman; S P Manninger; Y Qiang; A M Spence; S I Stupp; M Zhang; E A Neuwelt
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

5.  MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium.

Authors:  V Dousset; B Brochet; M S A Deloire; L Lagoarde; B Barroso; J-M Caille; K G Petry
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

6.  Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI.

Authors:  Tjun Tang; Simon P S Howarth; Sam R Miller; Rikin Trivedi; Martin J Graves; Jean U King-Im; Zhi Y Li; Andrew P Brown; Peter J Kirkpatrick; Michael E Gaunt; Jonathan H Gillard
Journal:  Stroke       Date:  2006-08-17       Impact factor: 7.914

7.  Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse.

Authors:  Willem J M Mulder; Kim Douma; Gerben A Koning; Marc A van Zandvoort; Esther Lutgens; Mat J Daemen; Klaas Nicolay; Gustav J Strijkers
Journal:  Magn Reson Med       Date:  2006-05       Impact factor: 4.668

8.  Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE.

Authors:  B Brochet; M S A Deloire; T Touil; O Anne; J M Caillé; V Dousset; K G Petry
Journal:  Neuroimage       Date:  2006-05-02       Impact factor: 6.556

9.  Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent.

Authors:  Philippe Bourrinet; Howard H Bengele; Bruno Bonnemain; Anne Dencausse; Jean-Marc Idee; Paula M Jacobs; Jerome M Lewis
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

10.  Fast and quiet MRI using a swept radiofrequency.

Authors:  Djaudat Idiyatullin; Curt Corum; Jang-Yeon Park; Michael Garwood
Journal:  J Magn Reson       Date:  2006-06-19       Impact factor: 2.229

View more
  136 in total

Review 1.  Magnetic nanoparticles in magnetic resonance imaging and diagnostics.

Authors:  Christine Rümenapp; Bernhard Gleich; Axel Haase
Journal:  Pharm Res       Date:  2012-03-06       Impact factor: 4.200

2.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

3.  Ferumoxytol-enhanced MRI differentiation of meningioma from dural metastases: a pilot study with immunohistochemical observations.

Authors:  Bronwyn E Hamilton; Randall L Woltjer; Joao Prola-Netto; Gary M Nesbit; Seymur Gahramanov; Thao Pham; Jaime Wagner; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

Review 4.  Targeting specific cells in the brain with nanomedicines for CNS therapies.

Authors:  Fan Zhang; Yi-An Lin; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2015-12-11       Impact factor: 9.776

Review 5.  Molecular imaging of cerebrovascular lesions.

Authors:  Nohra Chalouhi; Pascal Jabbour; Vincent Magnotta; David Hasan
Journal:  Transl Stroke Res       Date:  2013-10-23       Impact factor: 6.829

6.  Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.

Authors:  Morad Nasseri; Seymur Gahramanov; Joao Prola Netto; Rongwei Fu; Leslie L Muldoon; Csanad Varallyay; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2014-02-11       Impact factor: 12.300

7.  Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.

Authors:  Liya Wang; Xiaodong Zhong; Weiping Qian; Jing Huang; Zehong Cao; Qiqi Yu; Malgorzata Lipowska; Run Lin; Andrew Wang; Lily Yang; Hui Mao
Journal:  J Magn Reson Imaging       Date:  2014-11       Impact factor: 4.813

Review 8.  Handling of iron oxide and silver nanoparticles by astrocytes.

Authors:  Michaela C Hohnholt; Mark Geppert; Eva M Luther; Charlotte Petters; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-12-06       Impact factor: 3.996

9.  Markers of cochlear inflammation using MRI.

Authors:  Johann Le Floc'h; Winston Tan; Ravindra S Telang; Srdjan M Vlajkovic; Alfred Nuttall; William D Rooney; Beau Pontré; Peter R Thorne
Journal:  J Magn Reson Imaging       Date:  2013-04-15       Impact factor: 4.813

10.  Coating Evaluation and Purification of Monodisperse, Water-Soluble, Magnetic Nanoparticles Using Sucrose Density Gradient Ultracentrifugation.

Authors:  Andrew M Prantner; Jun Chen; Christopher B Murray; Nathalie Scholler
Journal:  Chem Mater       Date:  2012-10-19       Impact factor: 9.811

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.